BioXcel Therapeutics (BTAI)
(Delayed Data from NSDQ)
$1.17 USD
0.00 (0.00%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $1.17 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.76 |
EPS Last Quarter | -0.87 |
Last EPS Surprise | -27.94% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.74 |
Next Year | -1.75 |
EPS (TTM) | -5.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.80M | 0.91M | 3.41M | 11.76M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.80M | 0.91M | 3.41M | 11.76M |
Low Estimate | 0.80M | 0.91M | 3.41M | 11.76M |
Year ago Sales | 0.46M | 0.34M | 1.38M | 3.41M |
Year over Year Growth Est. | 73.91% | 167.65% | 147.10% | 244.87% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.76 | -0.65 | -2.74 | -1.75 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | -0.76 | -0.65 | -2.79 | -1.57 |
High Estimate | -0.76 | -0.65 | -2.68 | -1.57 |
Low Estimate | -0.76 | -0.65 | -2.79 | -1.92 |
Year ago EPS | -1.83 | -1.72 | -6.15 | -2.74 |
Year over Year Growth Est. | 58.47% | 62.21% | 55.45% | 36.13% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.76 | -0.65 | -2.74 | -1.75 |
7 Days Ago | -0.76 | -0.65 | -2.74 | -1.75 |
30 Days Ago | -0.76 | -0.65 | -2.61 | -1.86 |
60 Days Ago | -0.76 | -0.65 | -2.61 | -1.86 |
90 Days Ago | -0.63 | -0.59 | -2.46 | -1.85 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.76 | -0.65 | -2.74 | -1.75 |
Zacks Consensus Estimate | -0.76 | -0.65 | -2.74 | -1.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.87 | -0.76 | -1.72 | -1.83 | NA |
Estimate | -0.68 | -0.98 | -1.29 | -1.72 | NA |
Difference | -0.19 | 0.22 | -0.43 | -0.11 | -0.13 |
Surprise | -27.94% | 22.45% | -33.33% | -6.40% | -11.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more